Product Details

Invega Sustenna

Paliperidone Palmitate
150 mg/1.5 mL
Prolonged-Release Injectable Suspension
Prefilled Syringe

DIN/PIN/NPN

02354241

Manufacturer

Janssen Inc.

Formulary Listing Date

2012-01-19  

Unit Price

725.9100

Amount MOH Pays

725.9100

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Paliperidone Palmitate 150 mg/1.5 mL Prolonged-Release Injectable Suspension in Prefilled Syringe: For the treatment of schizophrenia or schizoaffective disorders in patients who have: A history of non-adherence; AND one of the following: (a) Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; OR (b) Inadequate control or significant side-effects from one or more conventional depot antipsychotic agents.

ATC Code

N05AX13

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph